Global Gastric Ulcers Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

The Gastric Ulcers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Gastric Ulcers Market Size Expected to Be by 2034?
The gastric ulcers market has seen strong growth in recent years. It is expected to grow from $4.29 billion in 2024 to $4.54 billion in 2025, at a CAGR of 5.9%. The growth is linked to the rising prevalence of Helicobacter pylori infections, increased use of NSAIDs, and rising awareness campaigns about gastric ulcers.

The gastric ulcers market is projected to grow substantially in the coming years, reaching $5.64 billion by 2029 with a CAGR of 5.5%. Factors contributing to this growth include advancements in diagnostic methods, rising unhealthy dietary habits, new treatment options like proton pump inhibitors (PPIs), an aging population leading to a higher disease burden, and the expansion of healthcare infrastructure in emerging markets. Notable trends include a shift to combination therapies for better outcomes, growing preference for minimally invasive treatments, the integration of digital health solutions, increasing demand for over-the-counter (OTC) ulcer medications, and the move toward personalized treatment options.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17160

What Are the Emerging Segments Within the Gastric Ulcers Market?
The gastric ulcers market covered in this report is segmented -

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes
2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:
1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole
2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate
4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline
5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate
6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

What Long-Term Drivers Are Shaping Gastric Ulcers Market Trends?
The rising elderly population is projected to boost the gastric ulcers market. The geriatric demographic includes individuals aged 65 and above, often requiring specialized medical attention due to age-related health concerns. The increase in this age group results from medical advancements, greater life expectancy, and declining birth rates globally. Older adults are more prone to gastric ulcers due to factors such as increased NSAID use and diminished mucosal defense. For example, in January 2024, the Population Reference Bureau reported that the US population aged 65+ is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% rise. Their share of the total population will grow from 17% to 23%. Therefore, the growing elderly population is driving the gastric ulcers market.

Who Are the Top Competitors in Key Gastric Ulcers Market Segments?
Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

What Trends Are Expected to Dominate the Gastric Ulcers Market in the Next 5 Years?
Major corporations active in the gastric ulcer market are concentrating on producing innovative items, such as drug formulations, to boost treatment results and minimize side effects. These new formulation drugs are ones that use unique combinations of active ingredients, delivery mechanisms, or dosages to improve their efficiency, safety, and adherence by patients. Take for example, Akums Drugs and Pharmaceuticals Ltd., a pharmaceutical manufacturing firm based in India, which introduced Rabeprazole + Levosulpiride SR Capsules in June 2024. These capsules are aimed at aiding conditions such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. By mixing a proton pump inhibitor and a prokinetic agent, these products efficiently treat gastrointestinal issues including gastroesophageal reflux disease (GERD) and gastric ulcers. This formulation successfully decreases gastric acid production while also improving gastric movement, offering thorough alleviation from symptoms like heartburn and indigestion.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Which Regions Are Becoming Hubs for Gastric Ulcers Market Innovation?
North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gastric Ulcers Market?
2. What is the CAGR expected in the Gastric Ulcers Market?
3. What Are the Key Innovations Transforming the Gastric Ulcers Industry?
4. Which Region Is Leading the Gastric Ulcers Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.